PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), which accounts for about 10% of all breast cancer cases, is defined by the absence of ER (estrogen receptor) and PR (progesterone receptor) expression, together with lack of HER2 (human epidermal growth factor 2 receptor) gene amplification or protein overexpression at diagnosis.